Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS’ 2014 draft hospital outpatient prospective payment system proposes cuts to CT and MRI and increases for radiation therapy. OIG recommends New York Medicaid set competitive bidding program for test strips. More reimbursement news.

You may also be interested in...



Reimbursement Briefs: Physician, Hospital Outpatient Rules; Equipment Maintenance Directive

Radiation therapy reimbursement up in 2014 final physician fee schedule, flat in hospital outpatient prospective payment system. Final 2014 OPPS makes changes to Hospital Outpatient Quality Reporting Program. More reimbursement briefs.

CMS Advisors And Industry Groups Press Agency To Delay Outpatient System Changes

CMS faces pressure from one of its advisory panels and the device industry to delay implementation of proposals in its draft 2014 hospital outpatient payment rule related to the development of comprehensive ambulatory payment classifications, implementation of new cost centers for CT and MRI, and seven new packaging policies.

Correction Means Lower Medicare Outpatient Rates Than Expected For Stereotactic Radiosurgery

A correction notice issued by CMS to fix technical errors in the 2014 draft hospital outpatient prospective payment system cut its payment proposal for stereotactic radiosurgery by about $3,000 compared to a proposed rule issued in July.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT032231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel